No Data
No Data
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announ
LSL Pharma Group Raises $1.5-million in the First Tranche of a Private Placement of Share Units
LSL Pharma Group (LSL.V) on Thursday said it raised $1.5 million in the first tranche of its non-brokered private placement of share units. The company placed 3.73-million units in the financing, with
LSL Pharma to Raise $4.5 Million Via Private Placements
LSL Pharma Group (LSL.V), a Canadian pharmaceutical company, said on Wednesday that it plans to raise $4.5 Million via a combination of private placements. LSL intends to raise a maximum of $3 million
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
LSL Pharma Group (LSL.V) on Monday said it will acquire a rival pharmaceutical manufacturer for $2.5 million in cash to expand its contract-manufacturing of natural health products. LSL identified the
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023 of $8
LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units
08:37 AM EDT, 04/24/2024 (MT Newswires) -- LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units